Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
OpenEvidence, an AI tool for doctors, raised $200 million, valuing it at $6 billion to expand its clinical decision support.
OpenEvidence, a medical AI platform often described as "ChatGPT for doctors," has secured $200 million in funding, valuing the company at $6 billion.
The round, led by prominent investors, marks a significant milestone for the company aiming to assist healthcare professionals with evidence-based clinical decision support.
The funding will support expanding its AI-driven tools, enhancing data accuracy, and broadening adoption across U.S. hospitals and clinics.
3 Articles
OpenEvidence, una herramienta de IA para médicos, recaudó $ 200 millones, valorándola en $ 6 mil millones para expandir su apoyo a la toma de decisiones clínicas.